Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera

被引：8
|
作者：
Krecak, Ivan [1 ]
Holik, Hrvoje [2 ]
Coha, Bozena [2 ]
Peric, Martina Moric [3 ]
Zekanovic, Ivan [3 ]
Krecak, Marija Valovicic [4 ]
Gveric-Krecak, Velka [1 ]
Lucijanic, Marko [5 ,6 ]
机构：
[1] Gen Hosp Sibenik Knin Cty, Dept Internal Med, Stjepana Radica 83, Shibenik 22000, Croatia
[2] Dr Josip Bencevic Gen Hosp, Dept Internal Med, Slavonski Brod, Croatia
[3] Gen Hosp Zadar, Dept Internal Med, Zadar, Croatia
[4] Gen Hosp Sibenik Knin Cty, Dept Psychiat, Shibenik, Croatia
[5] Univ Hosp Dubrava, Zagreb, Croatia
[6] Univ Zagreb, Sch Med, Zagreb, Croatia
来源：
ANNALS OF HEMATOLOGY | 2021年 / 100卷 / 05期
关键词：
STATINS;
D O I：
10.1007/s00277-021-04431-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1335 / 1336
页数：2
相关论文
共 50 条
  • [1] Low-density lipoprotein (LDL) and the risk of thrombotic events in essential thrombocythemia and polycythemia vera
    Ivan Krečak
    Hrvoje Holik
    Božena Coha
    Martina Morić Perić
    Ivan Zekanović
    Marija Valovičić Krečak
    Velka Gverić-Krečak
    Marko Lucijanić
    Annals of Hematology, 2021, 100 : 1335 - 1336
  • [2] Thrombotic events and mortality risk in patients with newly diagnosed polycythemia vera or essential thrombocythemia
    Pemmaraju, Naveen
    Gerds, Aaron T.
    Yu, Jingbo
    Parasuraman, Shreekant
    Shah, Anne
    Xi, Ann
    Kumar, Shambhavi
    Scherber, Robyn M.
    Verstovsek, Srdan
    LEUKEMIA RESEARCH, 2022, 115
  • [3] Cardiovascular Risk in Essential Thrombocythemia and Polycythemia Vera: Thrombotic Risk and Survival
    Accurso, Vincenzo
    Santoro, Marco
    Mancuso, Salvatrice
    Contrino, Angelo Davide
    Casimiro, Paolo
    Sardo, Mariano
    Raso, Simona
    Di Piazza, Florinda
    Perez, Alessandro
    Bono, Marco
    Russo, Antonio
    Siragusa, Sergio
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2020, 12
  • [4] Platelet density in essential thrombocythemia and polycythemia vera
    Järemo, P
    PLATELETS, 1999, 10 (01) : 61 - 63
  • [5] Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera
    Posfai, Eva
    Marton, Imelda
    Borbenyi, Zita
    Nemes, Attila
    ANATOLIAN JOURNAL OF CARDIOLOGY, 2016, 16 (06): : 397 - 402
  • [6] The risk of thrombosis in essential thrombocythemia and polycythemia vera
    Pearson, TC
    SEMINARS IN ONCOLOGY, 2002, 29 (03) : 16 - 21
  • [7] Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden
    Lim, Yoojoo
    Lee, Jeong-Ok
    Kim, Se Hyun
    Kim, Jin Won
    Kim, Yu Jung
    Lee, Keun-Wook
    Lee, Jong Seok
    Bang, Soo-Mee
    THROMBOSIS RESEARCH, 2015, 135 (05) : 846 - 851
  • [8] Evaluation of Therapeutic Strategies to Reduce the Number of Thrombotic Events in Patients With Polycythemia Vera and Essential Thrombocythemia
    Tremblay, Douglas
    Kosiorek, Heidi E.
    Dueck, Amylou C.
    Hoffman, Ronald
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [9] Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia:: A cohort study
    Gisslinger, H
    Müllner, M
    Pabinger, I
    Heis-Vahidi-Fard, N
    Gisslinger, B
    Brichta, A
    Bachleitner-Hofmann, T
    Mannhalter, C
    HAEMATOLOGICA, 2005, 90 (03) : 408 - 410
  • [10] Essential thrombocythemia and polycythemia vera
    Griesshammer, Martin
    Kvasnicka, Hans M. M.
    Koschmieder, Steffen
    ONKOLOGIE, 2023, 29 (04): : 296 - 304
12345